PreOmics

Executive Summary

PreOmics is a German proteomics company founded in 2016, specializing in sample preparation solutions and consumables for mass spectrometry-based protein analysis. The company provides a comprehensive portfolio of kits, automation platforms, and LC columns designed to streamline and standardize proteomics workflows for research and diagnostics. Its core technology, the iST (in-StageTip) platform, enables fast, reproducible preparation of proteins and peptides from various sample types. Despite a strong product portfolio and focus on standardizing proteomics, the company remains in the pre-clinical stage and has not disclosed significant funding rounds or valuation. However, its position in the growing proteomics market, driven by increasing adoption of mass spectrometry in clinical diagnostics, presents a moderate opportunity. The company's success hinges on expanding its commercial reach, securing partnerships with diagnostic labs, and potentially moving into regulated clinical applications.

Upcoming Catalysts (preview)

• Q3 2026Launch of new automation platform or kit for clinical diagnostics70% success
• Q4 2026Strategic partnership with a major diagnostic company or CRO50% success
• Q2 2027Series A or B funding round from life sciences investors40% success